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We have studied the recruitment of adoptively transferred
tumor-specific CD8-positive T cells in a mouse model sys-
tem. Subcutaneous tumors of the transgenic, ovalbumin-
expressing murine melanoma cell line B16-OVA were
established in mice, which subsequently received intrave-
nous transfer of ovalbumin-specific T cells, derived from
the mouse strain OT-I, transgenic for a T cell receptor rec-
ognizing an ovalbumin-derived peptide, SIINFEKL.
Specific T cells from OT-I spleen were expanded in culture
in the presence of SIINFEKL peptide prior to transfer. The
homing of adoptively transferred cells to B16-OVA
tumors was demonstrated using several methods, and the
kinetics of the accumulation of the cells in the tumor tis-
sue was delineated by flow cytometry. Quantitative meas-
urements of the content of SIINFEKL/H-2 Kb tetramer and
CD8 double positive cells in single cell suspensions from
extirpated, collagenase treated tumors were performed
each day for 8 consecutive days following adoptive trans-
fer. The presence of double positive cells increased gradu-
ally until day 5, when an average number of 3.3 × 106 (n
= 9) double positive cells per gram tumor tissue was
found. The number of double positive cells per gram
tumor remained fairly constant until day 8, which was the
latest day examined.
Our results establish a baseline for the tumor accumula-
tion of transferred T cells in this model, and form a foun-
dation for studies of different experimental protocols for
adoptive transfer of T cells. Monitoring the effect on the
specific accumulation of transferred T cells in this model
we are presently studying various strategies for injecting
and supporting the transferred cells. Results from these
investigations could hopefully contribute towards opti-
mizing adoptive immunotherapy of cancer in human sub-
jects.
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